nodes	percent_of_prediction	percent_of_DWPC	metapath
Mimosine—CCL2—hematologic cancer	0.451	1	CbGaD
Mimosine—L-Tyrosine—Melphalan—hematologic cancer	0.226	0.586	CrCrCtD
Mimosine—L-DOPA—Melphalan—hematologic cancer	0.16	0.415	CrCrCtD
Mimosine—TYR—hematopoietic system—hematologic cancer	0.00621	0.141	CbGeAlD
Mimosine—TYR—blood—hematologic cancer	0.00411	0.0933	CbGeAlD
Mimosine—SHMT1—hematopoietic system—hematologic cancer	0.00385	0.0872	CbGeAlD
Mimosine—CCL2—hematopoietic system—hematologic cancer	0.00357	0.0808	CbGeAlD
Mimosine—L-DOPA—PSIP1—hematologic cancer	0.00309	1	CrCbGaD
Mimosine—SHMT1—gonad—hematologic cancer	0.00293	0.0663	CbGeAlD
Mimosine—SHMT1—blood—hematologic cancer	0.00255	0.0578	CbGeAlD
Mimosine—SHMT1—bone marrow—hematologic cancer	0.00247	0.0559	CbGeAlD
Mimosine—TYR—lymph node—hematologic cancer	0.00247	0.0559	CbGeAlD
Mimosine—CCL2—blood—hematologic cancer	0.00236	0.0536	CbGeAlD
Mimosine—CCL2—bone marrow—hematologic cancer	0.00229	0.0518	CbGeAlD
Mimosine—SHMT1—lung—hematologic cancer	0.00223	0.0507	CbGeAlD
Mimosine—SHMT1—testis—hematologic cancer	0.00211	0.0478	CbGeAlD
Mimosine—CCL2—lung—hematologic cancer	0.00207	0.047	CbGeAlD
Mimosine—CCL2—testis—hematologic cancer	0.00195	0.0443	CbGeAlD
Mimosine—SHMT1—lymph node—hematologic cancer	0.00153	0.0347	CbGeAlD
Mimosine—CCL2—lymph node—hematologic cancer	0.00142	0.0321	CbGeAlD
Mimosine—SHMT1—Podofilox—Teniposide—hematologic cancer	0.000489	0.11	CbGdCrCtD
Mimosine—SHMT1—Vincristine—Vinorelbine—hematologic cancer	0.000311	0.0701	CbGdCrCtD
Mimosine—SHMT1—Podofilox—Etoposide—hematologic cancer	0.000291	0.0654	CbGdCrCtD
Mimosine—SHMT1—Vinblastine—Vinorelbine—hematologic cancer	0.00025	0.0563	CbGdCrCtD
Mimosine—SHMT1—Vincristine—Vinblastine—hematologic cancer	0.000249	0.056	CbGdCrCtD
Mimosine—SHMT1—Vinblastine—Vincristine—hematologic cancer	0.0002	0.045	CbGdCrCtD
Mimosine—CCL2—Methylprednisolone—Betamethasone—hematologic cancer	7.3e-05	0.0164	CbGdCrCtD
Mimosine—CCL2—Methylprednisolone—Dexamethasone—hematologic cancer	7.3e-05	0.0164	CbGdCrCtD
Mimosine—CCL2—Methylprednisolone—Triamcinolone—hematologic cancer	7.14e-05	0.0161	CbGdCrCtD
Mimosine—CCL2—Methylprednisolone—Prednisone—hematologic cancer	6.77e-05	0.0152	CbGdCrCtD
Mimosine—CCL2—Methylprednisolone—Prednisolone—hematologic cancer	6.61e-05	0.0149	CbGdCrCtD
Mimosine—CCL2—Beclomethasone—Dexamethasone—hematologic cancer	6.55e-05	0.0147	CbGdCrCtD
Mimosine—CCL2—Beclomethasone—Betamethasone—hematologic cancer	6.55e-05	0.0147	CbGdCrCtD
Mimosine—CCL2—Beclomethasone—Triamcinolone—hematologic cancer	6.4e-05	0.0144	CbGdCrCtD
Mimosine—CCL2—Fluocinonide—Dexamethasone—hematologic cancer	6.04e-05	0.0136	CbGdCrCtD
Mimosine—CCL2—Fluocinonide—Betamethasone—hematologic cancer	6.04e-05	0.0136	CbGdCrCtD
Mimosine—CCL2—Beclomethasone—Prednisolone—hematologic cancer	5.93e-05	0.0133	CbGdCrCtD
Mimosine—CCL2—Fluocinonide—Triamcinolone—hematologic cancer	5.9e-05	0.0133	CbGdCrCtD
Mimosine—CCL2—Amcinonide—Betamethasone—hematologic cancer	5.79e-05	0.013	CbGdCrCtD
Mimosine—CCL2—Amcinonide—Dexamethasone—hematologic cancer	5.79e-05	0.013	CbGdCrCtD
Mimosine—CCL2—Amcinonide—Triamcinolone—hematologic cancer	5.66e-05	0.0127	CbGdCrCtD
Mimosine—CCL2—Amcinonide—Prednisone—hematologic cancer	5.37e-05	0.0121	CbGdCrCtD
Mimosine—CCL2—Amcinonide—Prednisolone—hematologic cancer	5.24e-05	0.0118	CbGdCrCtD
Mimosine—CCL2—Signaling by GPCR—ADCY7—hematologic cancer	4.67e-05	0.000421	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SPHK1—hematologic cancer	4.65e-05	0.000419	CbGpPWpGaD
Mimosine—SHMT1—Disease—XIAP—hematologic cancer	4.62e-05	0.000417	CbGpPWpGaD
Mimosine—SHMT1—Disease—MTR—hematologic cancer	4.62e-05	0.000417	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ARHGEF1—hematologic cancer	4.55e-05	0.00041	CbGpPWpGaD
Mimosine—SHMT1—Disease—ENO2—hematologic cancer	4.53e-05	0.000409	CbGpPWpGaD
Mimosine—CCL2—Fluorometholone—Betamethasone—hematologic cancer	4.53e-05	0.0102	CbGdCrCtD
Mimosine—CCL2—Fluorometholone—Dexamethasone—hematologic cancer	4.53e-05	0.0102	CbGdCrCtD
Mimosine—SHMT1—Disease—SMARCA4—hematologic cancer	4.5e-05	0.000406	CbGpPWpGaD
Mimosine—CCL2—Flurandrenolide—Betamethasone—hematologic cancer	4.5e-05	0.0101	CbGdCrCtD
Mimosine—CCL2—Flurandrenolide—Dexamethasone—hematologic cancer	4.5e-05	0.0101	CbGdCrCtD
Mimosine—SHMT1—Metabolism—UGT1A1—hematologic cancer	4.46e-05	0.000402	CbGpPWpGaD
Mimosine—CCL2—Fluorometholone—Triamcinolone—hematologic cancer	4.42e-05	0.00995	CbGdCrCtD
Mimosine—SHMT1—Metabolism—SLC22A1—hematologic cancer	4.34e-05	0.000391	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CRABP1—hematologic cancer	4.34e-05	0.000391	CbGpPWpGaD
Mimosine—SHMT1—Disease—SDC1—hematologic cancer	4.3e-05	0.000387	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CCL3—hematologic cancer	4.27e-05	0.000385	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ALOX5—hematologic cancer	4.23e-05	0.000381	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PTHLH—hematologic cancer	4.22e-05	0.00038	CbGpPWpGaD
Mimosine—CCL2—Fluorometholone—Prednisone—hematologic cancer	4.2e-05	0.00944	CbGdCrCtD
Mimosine—SHMT1—Disease—LCK—hematologic cancer	4.16e-05	0.000375	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PTGER4—hematologic cancer	4.11e-05	0.00037	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NUP98—hematologic cancer	4.1e-05	0.000369	CbGpPWpGaD
Mimosine—CCL2—Fluorometholone—Prednisolone—hematologic cancer	4.1e-05	0.00922	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—AGRN—hematologic cancer	4.08e-05	0.000368	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCL17—hematologic cancer	4.08e-05	0.000368	CbGpPWpGaD
Mimosine—SHMT1—Disease—H3F3A—hematologic cancer	4.08e-05	0.000368	CbGpPWpGaD
Mimosine—CCL2—Flurandrenolide—Prednisolone—hematologic cancer	4.07e-05	0.00916	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—CXCR5—hematologic cancer	4.01e-05	0.000361	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ADCY7—hematologic cancer	3.98e-05	0.000359	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NCOA3—hematologic cancer	3.98e-05	0.000359	CbGpPWpGaD
Mimosine—SHMT1—Disease—PRKCZ—hematologic cancer	3.96e-05	0.000357	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NUP214—hematologic cancer	3.95e-05	0.000356	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LEF1—hematologic cancer	3.93e-05	0.000355	CbGpPWpGaD
Mimosine—SHMT1—Disease—CALR—hematologic cancer	3.89e-05	0.000351	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—MTR—hematologic cancer	3.87e-05	0.000349	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ABCG2—hematologic cancer	3.87e-05	0.000349	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GNA13—hematologic cancer	3.87e-05	0.000349	CbGpPWpGaD
Mimosine—SHMT1—Disease—PARP1—hematologic cancer	3.83e-05	0.000345	CbGpPWpGaD
Mimosine—CCL2—Clobetasol propionate—Dexamethasone—hematologic cancer	3.83e-05	0.00861	CbGdCrCtD
Mimosine—CCL2—Clobetasol propionate—Betamethasone—hematologic cancer	3.83e-05	0.00861	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—TIAM1—hematologic cancer	3.81e-05	0.000343	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ENO2—hematologic cancer	3.8e-05	0.000342	CbGpPWpGaD
Mimosine—CCL2—Flunisolide—Betamethasone—hematologic cancer	3.78e-05	0.0085	CbGdCrCtD
Mimosine—CCL2—Flunisolide—Dexamethasone—hematologic cancer	3.78e-05	0.0085	CbGdCrCtD
Mimosine—SHMT1—Disease—FBXW7—hematologic cancer	3.77e-05	0.00034	CbGpPWpGaD
Mimosine—CCL2—Clobetasol propionate—Triamcinolone—hematologic cancer	3.74e-05	0.00842	CbGdCrCtD
Mimosine—CCL2—Triamcinolone—Betamethasone—hematologic cancer	3.74e-05	0.00841	CbGdCrCtD
Mimosine—CCL2—Triamcinolone—Dexamethasone—hematologic cancer	3.74e-05	0.00841	CbGdCrCtD
Mimosine—SHMT1—Disease—CXCR4—hematologic cancer	3.69e-05	0.000333	CbGpPWpGaD
Mimosine—SHMT1—Disease—HDAC2—hematologic cancer	3.69e-05	0.000333	CbGpPWpGaD
Mimosine—CCL2—Flunisolide—Triamcinolone—hematologic cancer	3.69e-05	0.00831	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—JAK3—hematologic cancer	3.69e-05	0.000333	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GSTT1—hematologic cancer	3.68e-05	0.000332	CbGpPWpGaD
Mimosine—SHMT1—Disease—CD44—hematologic cancer	3.65e-05	0.000329	CbGpPWpGaD
Mimosine—CCL2—Fluticasone Propionate—Betamethasone—hematologic cancer	3.65e-05	0.00821	CbGdCrCtD
Mimosine—CCL2—Fluticasone Propionate—Dexamethasone—hematologic cancer	3.65e-05	0.00821	CbGdCrCtD
Mimosine—CCL2—Signaling by GPCR—CXCR4—hematologic cancer	3.63e-05	0.000327	CbGpPWpGaD
Mimosine—SHMT1—Disease—CBL—hematologic cancer	3.6e-05	0.000325	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—SDC1—hematologic cancer	3.6e-05	0.000324	CbGpPWpGaD
Mimosine—CCL2—Fluticasone Propionate—Triamcinolone—hematologic cancer	3.56e-05	0.00802	CbGdCrCtD
Mimosine—CCL2—Desoximetasone—Betamethasone—hematologic cancer	3.55e-05	0.00799	CbGdCrCtD
Mimosine—CCL2—Desoximetasone—Dexamethasone—hematologic cancer	3.55e-05	0.00799	CbGdCrCtD
Mimosine—CCL2—Clobetasol propionate—Prednisone—hematologic cancer	3.55e-05	0.00799	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—CXCL13—hematologic cancer	3.54e-05	0.000319	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCR7—hematologic cancer	3.54e-05	0.000319	CbGpPWpGaD
Mimosine—CCL2—Flunisolide—Prednisone—hematologic cancer	3.5e-05	0.00788	CbGdCrCtD
Mimosine—CCL2—Signaling by GPCR—IL3—hematologic cancer	3.5e-05	0.000315	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NCOR2—hematologic cancer	3.49e-05	0.000315	CbGpPWpGaD
Mimosine—CCL2—Desoximetasone—Triamcinolone—hematologic cancer	3.47e-05	0.00781	CbGdCrCtD
Mimosine—CCL2—Triamcinolone—Prednisone—hematologic cancer	3.47e-05	0.0078	CbGdCrCtD
Mimosine—CCL2—Clobetasol propionate—Prednisolone—hematologic cancer	3.46e-05	0.0078	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—IL3RA—hematologic cancer	3.45e-05	0.000311	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CRKL—hematologic cancer	3.45e-05	0.000311	CbGpPWpGaD
Mimosine—CCL2—Diflorasone—Betamethasone—hematologic cancer	3.45e-05	0.00776	CbGdCrCtD
Mimosine—CCL2—Diflorasone—Dexamethasone—hematologic cancer	3.45e-05	0.00776	CbGdCrCtD
Mimosine—SHMT1—Disease—HSP90AA1—hematologic cancer	3.43e-05	0.00031	CbGpPWpGaD
Mimosine—CCL2—Flunisolide—Prednisolone—hematologic cancer	3.42e-05	0.00769	CbGdCrCtD
Mimosine—CCL2—Triamcinolone—Prednisolone—hematologic cancer	3.38e-05	0.00762	CbGdCrCtD
Mimosine—CCL2—Signaling by GPCR—RASGRP1—hematologic cancer	3.38e-05	0.000305	CbGpPWpGaD
Mimosine—CCL2—Diflorasone—Triamcinolone—hematologic cancer	3.37e-05	0.00758	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—RGS2—hematologic cancer	3.33e-05	0.0003	CbGpPWpGaD
Mimosine—SHMT1—Disease—STAT1—hematologic cancer	3.31e-05	0.000299	CbGpPWpGaD
Mimosine—CCL2—Desoximetasone—Prednisone—hematologic cancer	3.29e-05	0.00741	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—TRIO—hematologic cancer	3.29e-05	0.000297	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TRH—hematologic cancer	3.29e-05	0.000297	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CMA1—hematologic cancer	3.29e-05	0.000297	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SPHK1—hematologic cancer	3.22e-05	0.00029	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AGO2—hematologic cancer	3.22e-05	0.00029	CbGpPWpGaD
Mimosine—CCL2—Desoximetasone—Prednisolone—hematologic cancer	3.21e-05	0.00723	CbGdCrCtD
Mimosine—CCL2—Diflorasone—Prednisone—hematologic cancer	3.2e-05	0.00719	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—HDAC9—hematologic cancer	3.19e-05	0.000287	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LPAR1—hematologic cancer	3.19e-05	0.000287	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—H3F3B—hematologic cancer	3.15e-05	0.000284	CbGpPWpGaD
Mimosine—CCL2—Diflorasone—Prednisolone—hematologic cancer	3.12e-05	0.00702	CbGdCrCtD
Mimosine—SHMT1—Disease—GRB2—hematologic cancer	3.1e-05	0.000279	CbGpPWpGaD
Mimosine—SHMT1—Disease—PDGFA—hematologic cancer	3.09e-05	0.000279	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NQO1—hematologic cancer	3.06e-05	0.000276	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CD44—hematologic cancer	3.06e-05	0.000276	CbGpPWpGaD
Mimosine—SHMT1—Disease—KITLG—hematologic cancer	3.05e-05	0.000275	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—GRB2—hematologic cancer	3.04e-05	0.000274	CbGpPWpGaD
Mimosine—CCL2—Budesonide—Dexamethasone—hematologic cancer	3.02e-05	0.0068	CbGdCrCtD
Mimosine—CCL2—Budesonide—Betamethasone—hematologic cancer	3.02e-05	0.0068	CbGdCrCtD
Mimosine—SHMT1—Disease—STAT5A—hematologic cancer	2.98e-05	0.000268	CbGpPWpGaD
Mimosine—CCL2—Budesonide—Triamcinolone—hematologic cancer	2.95e-05	0.00664	CbGdCrCtD
Mimosine—SHMT1—Disease—CDKN2B—hematologic cancer	2.95e-05	0.000266	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PDE4B—hematologic cancer	2.93e-05	0.000264	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CNR2—hematologic cancer	2.93e-05	0.000264	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FGF19—hematologic cancer	2.91e-05	0.000262	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CYCS—hematologic cancer	2.89e-05	0.000261	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—RAC2—hematologic cancer	2.88e-05	0.00026	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—HSP90AA1—hematologic cancer	2.88e-05	0.000259	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—DKK1—hematologic cancer	2.86e-05	0.000258	CbGpPWpGaD
Mimosine—SHMT1—Disease—CD86—hematologic cancer	2.85e-05	0.000257	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—STAT5B—hematologic cancer	2.84e-05	0.000256	CbGpPWpGaD
Mimosine—SHMT1—Disease—HES1—hematologic cancer	2.82e-05	0.000254	CbGpPWpGaD
Mimosine—CCL2—Budesonide—Prednisone—hematologic cancer	2.8e-05	0.0063	CbGdCrCtD
Mimosine—SHMT1—Disease—NCOR1—hematologic cancer	2.8e-05	0.000252	CbGpPWpGaD
Mimosine—SHMT1—Disease—FGF1—hematologic cancer	2.77e-05	0.00025	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ADCY7—hematologic cancer	2.76e-05	0.000249	CbGpPWpGaD
Mimosine—CCL2—Budesonide—Prednisolone—hematologic cancer	2.73e-05	0.00615	CbGdCrCtD
Mimosine—SHMT1—Disease—FOXO1—hematologic cancer	2.73e-05	0.000246	CbGpPWpGaD
Mimosine—SHMT1—Disease—PDGFRB—hematologic cancer	2.72e-05	0.000246	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CSF2—hematologic cancer	2.72e-05	0.000245	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—XIAP—hematologic cancer	2.68e-05	0.000242	CbGpPWpGaD
Mimosine—SHMT1—Disease—PDGFRA—hematologic cancer	2.68e-05	0.000242	CbGpPWpGaD
Mimosine—SHMT1—Disease—JAK1—hematologic cancer	2.67e-05	0.000241	CbGpPWpGaD
Mimosine—SHMT1—Disease—PRKCG—hematologic cancer	2.67e-05	0.000241	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—JAK1—hematologic cancer	2.62e-05	0.000237	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PRKCG—hematologic cancer	2.62e-05	0.000237	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SH2B3—hematologic cancer	2.61e-05	0.000236	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SMARCA4—hematologic cancer	2.61e-05	0.000236	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—GZMB—hematologic cancer	2.6e-05	0.000234	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GSTP1—hematologic cancer	2.55e-05	0.00023	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CTNNA1—hematologic cancer	2.54e-05	0.000229	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—EIF4EBP1—hematologic cancer	2.52e-05	0.000227	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HSPB1—hematologic cancer	2.52e-05	0.000227	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCL3—hematologic cancer	2.52e-05	0.000227	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTHLH—hematologic cancer	2.49e-05	0.000225	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SDC1—hematologic cancer	2.49e-05	0.000225	CbGpPWpGaD
Mimosine—SHMT1—Disease—MTHFR—hematologic cancer	2.47e-05	0.000223	CbGpPWpGaD
Mimosine—SHMT1—Disease—TERT—hematologic cancer	2.47e-05	0.000222	CbGpPWpGaD
Mimosine—SHMT1—Disease—HLA-A—hematologic cancer	2.47e-05	0.000222	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL2RA—hematologic cancer	2.45e-05	0.000221	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTGER4—hematologic cancer	2.43e-05	0.000219	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ABCB1—hematologic cancer	2.42e-05	0.000218	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—LCK—hematologic cancer	2.41e-05	0.000218	CbGpPWpGaD
Mimosine—SHMT1—Disease—PDGFB—hematologic cancer	2.41e-05	0.000217	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—H3F3A—hematologic cancer	2.37e-05	0.000213	CbGpPWpGaD
Mimosine—SHMT1—Disease—TSC2—hematologic cancer	2.35e-05	0.000212	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—NCOR1—hematologic cancer	2.34e-05	0.000211	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—GSTM1—hematologic cancer	2.34e-05	0.000211	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PRKCZ—hematologic cancer	2.3e-05	0.000207	CbGpPWpGaD
Mimosine—SHMT1—Disease—FGFR3—hematologic cancer	2.26e-05	0.000204	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PARP1—hematologic cancer	2.22e-05	0.0002	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FBXW7—hematologic cancer	2.19e-05	0.000197	CbGpPWpGaD
Mimosine—SHMT1—Disease—BAD—hematologic cancer	2.15e-05	0.000194	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HDAC2—hematologic cancer	2.14e-05	0.000193	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CXCR4—hematologic cancer	2.14e-05	0.000193	CbGpPWpGaD
Mimosine—SHMT1—Disease—NOTCH1—hematologic cancer	2.13e-05	0.000192	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CBL—hematologic cancer	2.09e-05	0.000188	CbGpPWpGaD
Mimosine—SHMT1—Disease—CD80—hematologic cancer	2.08e-05	0.000188	CbGpPWpGaD
Mimosine—SHMT1—Disease—KIT—hematologic cancer	2.08e-05	0.000187	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—MTHFR—hematologic cancer	2.07e-05	0.000187	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL3—hematologic cancer	2.07e-05	0.000186	CbGpPWpGaD
Mimosine—SHMT1—Disease—PTPN11—hematologic cancer	2.04e-05	0.000184	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CG—hematologic cancer	2.04e-05	0.000184	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTPN1—hematologic cancer	2.03e-05	0.000183	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PTPN11—hematologic cancer	2.01e-05	0.000181	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—RASGRP1—hematologic cancer	2e-05	0.00018	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SYK—hematologic cancer	1.99e-05	0.00018	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HSP90AA1—hematologic cancer	1.99e-05	0.00018	CbGpPWpGaD
Mimosine—SHMT1—Disease—CREB1—hematologic cancer	1.98e-05	0.000178	CbGpPWpGaD
Mimosine—SHMT1—Disease—BRAF—hematologic cancer	1.95e-05	0.000176	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—CREB1—hematologic cancer	1.94e-05	0.000175	CbGpPWpGaD
Mimosine—SHMT1—Disease—IL6R—hematologic cancer	1.93e-05	0.000174	CbGpPWpGaD
Mimosine—SHMT1—Disease—CREBBP—hematologic cancer	1.93e-05	0.000174	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—STAT1—hematologic cancer	1.92e-05	0.000173	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL6R—hematologic cancer	1.9e-05	0.000171	CbGpPWpGaD
Mimosine—CCL2—Dexamethasone—Betamethasone—hematologic cancer	1.85e-05	0.00416	CbGdCrCtD
Mimosine—CCL2—Betamethasone—Dexamethasone—hematologic cancer	1.85e-05	0.00416	CbGdCrCtD
Mimosine—SHMT1—Disease—MAP2K1—hematologic cancer	1.84e-05	0.000166	CbGpPWpGaD
Mimosine—SHMT1—Disease—PIK3CD—hematologic cancer	1.83e-05	0.000165	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—MAP2K1—hematologic cancer	1.81e-05	0.000163	CbGpPWpGaD
Mimosine—CCL2—Betamethasone—Triamcinolone—hematologic cancer	1.81e-05	0.00406	CbGdCrCtD
Mimosine—CCL2—Dexamethasone—Triamcinolone—hematologic cancer	1.81e-05	0.00406	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—GRB2—hematologic cancer	1.8e-05	0.000162	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CD—hematologic cancer	1.8e-05	0.000162	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PDGFA—hematologic cancer	1.79e-05	0.000162	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—KITLG—hematologic cancer	1.77e-05	0.000159	CbGpPWpGaD
Mimosine—SHMT1—Disease—FGF2—hematologic cancer	1.75e-05	0.000158	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CG—hematologic cancer	1.74e-05	0.000157	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—STAT5A—hematologic cancer	1.73e-05	0.000156	CbGpPWpGaD
Mimosine—SHMT1—Disease—PIK3R1—hematologic cancer	1.73e-05	0.000156	CbGpPWpGaD
Mimosine—CCL2—Dexamethasone—Prednisone—hematologic cancer	1.71e-05	0.00386	CbGdCrCtD
Mimosine—CCL2—Betamethasone—Prednisone—hematologic cancer	1.71e-05	0.00386	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—CDKN2B—hematologic cancer	1.71e-05	0.000154	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3R1—hematologic cancer	1.7e-05	0.000153	CbGpPWpGaD
Mimosine—SHMT1—Disease—JAK2—hematologic cancer	1.68e-05	0.000151	CbGpPWpGaD
Mimosine—CCL2—Dexamethasone—Prednisolone—hematologic cancer	1.67e-05	0.00376	CbGdCrCtD
Mimosine—CCL2—Betamethasone—Prednisolone—hematologic cancer	1.67e-05	0.00376	CbGdCrCtD
Mimosine—CCL2—Signaling Pathways—CD86—hematologic cancer	1.66e-05	0.000149	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—JAK2—hematologic cancer	1.65e-05	0.000149	CbGpPWpGaD
Mimosine—SHMT1—Disease—MDM2—hematologic cancer	1.64e-05	0.000148	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HES1—hematologic cancer	1.63e-05	0.000147	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NCOR1—hematologic cancer	1.62e-05	0.000146	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—CREBBP—hematologic cancer	1.61e-05	0.000146	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CSF2—hematologic cancer	1.61e-05	0.000145	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FGF1—hematologic cancer	1.61e-05	0.000145	CbGpPWpGaD
Mimosine—SHMT1—Disease—MTOR—hematologic cancer	1.59e-05	0.000144	CbGpPWpGaD
Mimosine—SHMT1—Disease—PIK3CB—hematologic cancer	1.59e-05	0.000144	CbGpPWpGaD
Mimosine—SHMT1—Disease—CD4—hematologic cancer	1.59e-05	0.000143	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FOXO1—hematologic cancer	1.58e-05	0.000143	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PDGFRB—hematologic cancer	1.58e-05	0.000142	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CB—hematologic cancer	1.56e-05	0.000141	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PDGFRA—hematologic cancer	1.56e-05	0.00014	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PRKCG—hematologic cancer	1.55e-05	0.00014	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—JAK1—hematologic cancer	1.55e-05	0.00014	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CD—hematologic cancer	1.53e-05	0.000138	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—ALB—hematologic cancer	1.51e-05	0.000136	CbGpPWpGaD
Mimosine—SHMT1—Disease—CDKN1B—hematologic cancer	1.49e-05	0.000135	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL2RA—hematologic cancer	1.45e-05	0.000131	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3R1—hematologic cancer	1.45e-05	0.00013	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL2—hematologic cancer	1.44e-05	0.00013	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TERT—hematologic cancer	1.43e-05	0.000129	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PDGFB—hematologic cancer	1.4e-05	0.000126	CbGpPWpGaD
Mimosine—SHMT1—Disease—CDKN1A—hematologic cancer	1.38e-05	0.000124	CbGpPWpGaD
Mimosine—SHMT1—Disease—PTEN—hematologic cancer	1.38e-05	0.000124	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TSC2—hematologic cancer	1.37e-05	0.000123	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CB—hematologic cancer	1.33e-05	0.00012	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FGFR3—hematologic cancer	1.31e-05	0.000118	CbGpPWpGaD
Mimosine—SHMT1—Disease—EP300—hematologic cancer	1.31e-05	0.000118	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MAPK14—hematologic cancer	1.3e-05	0.000117	CbGpPWpGaD
Mimosine—SHMT1—Disease—SRC—hematologic cancer	1.28e-05	0.000115	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—ESR1—hematologic cancer	1.28e-05	0.000115	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FN1—hematologic cancer	1.26e-05	0.000114	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—BAD—hematologic cancer	1.25e-05	0.000112	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NFKBIA—hematologic cancer	1.25e-05	0.000112	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NOTCH1—hematologic cancer	1.23e-05	0.000111	CbGpPWpGaD
Mimosine—SHMT1—Disease—STAT3—hematologic cancer	1.23e-05	0.000111	CbGpPWpGaD
Mimosine—SHMT1—Disease—NRAS—hematologic cancer	1.23e-05	0.000111	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CD80—hematologic cancer	1.21e-05	0.000109	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—KIT—hematologic cancer	1.21e-05	0.000109	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CG—hematologic cancer	1.21e-05	0.000109	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—NRAS—hematologic cancer	1.21e-05	0.000109	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTPN11—hematologic cancer	1.19e-05	0.000107	CbGpPWpGaD
Mimosine—SHMT1—Disease—MAPK3—hematologic cancer	1.18e-05	0.000106	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—MAPK3—hematologic cancer	1.16e-05	0.000104	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PTEN—hematologic cancer	1.15e-05	0.000104	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CREB1—hematologic cancer	1.15e-05	0.000104	CbGpPWpGaD
Mimosine—SHMT1—Disease—MYC—hematologic cancer	1.14e-05	0.000103	CbGpPWpGaD
Mimosine—SHMT1—Disease—TGFB1—hematologic cancer	1.14e-05	0.000103	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—BRAF—hematologic cancer	1.13e-05	0.000102	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL6R—hematologic cancer	1.12e-05	0.000101	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CREBBP—hematologic cancer	1.12e-05	0.000101	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—EP300—hematologic cancer	1.1e-05	9.91e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MAP2K1—hematologic cancer	1.07e-05	9.62e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CD—hematologic cancer	1.06e-05	9.56e-05	CbGpPWpGaD
Mimosine—SHMT1—Disease—KRAS—hematologic cancer	1.06e-05	9.53e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—KRAS—hematologic cancer	1.04e-05	9.36e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—FGF2—hematologic cancer	1.02e-05	9.15e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3R1—hematologic cancer	1e-05	9.03e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—JAK2—hematologic cancer	9.73e-06	8.77e-05	CbGpPWpGaD
Mimosine—SHMT1—Disease—PIK3CA—hematologic cancer	9.71e-06	8.75e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—PIK3CA—hematologic cancer	9.54e-06	8.6e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MDM2—hematologic cancer	9.5e-06	8.56e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CB—hematologic cancer	9.24e-06	8.33e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MTOR—hematologic cancer	9.24e-06	8.33e-05	CbGpPWpGaD
Mimosine—SHMT1—Disease—HRAS—hematologic cancer	8.98e-06	8.1e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—HRAS—hematologic cancer	8.82e-06	7.96e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CDKN1B—hematologic cancer	8.67e-06	7.82e-05	CbGpPWpGaD
Mimosine—SHMT1—Disease—IL6—hematologic cancer	8.6e-06	7.75e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CASP3—hematologic cancer	8.5e-06	7.66e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL2—hematologic cancer	8.49e-06	7.65e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—IL6—hematologic cancer	8.45e-06	7.61e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CCND1—hematologic cancer	8.27e-06	7.46e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—JUN—hematologic cancer	8.26e-06	7.44e-05	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—PIK3CA—hematologic cancer	8.13e-06	7.33e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—CDKN1A—hematologic cancer	8.01e-06	7.22e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PTEN—hematologic cancer	7.99e-06	7.2e-05	CbGpPWpGaD
Mimosine—SHMT1—Disease—AKT1—hematologic cancer	7.93e-06	7.15e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MAPK8—hematologic cancer	7.81e-06	7.04e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling by GPCR—AKT1—hematologic cancer	7.79e-06	7.02e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—EP300—hematologic cancer	7.62e-06	6.87e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—SRC—hematologic cancer	7.41e-06	6.68e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—VEGFA—hematologic cancer	7.21e-06	6.5e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—STAT3—hematologic cancer	7.14e-06	6.44e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—NRAS—hematologic cancer	7.13e-06	6.42e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MAPK3—hematologic cancer	6.82e-06	6.15e-05	CbGpPWpGaD
Mimosine—SHMT1—Metabolism—AKT1—hematologic cancer	6.64e-06	5.99e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—MYC—hematologic cancer	6.64e-06	5.98e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TGFB1—hematologic cancer	6.62e-06	5.97e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—KRAS—hematologic cancer	6.13e-06	5.53e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—PIK3CA—hematologic cancer	5.63e-06	5.08e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—TP53—hematologic cancer	5.45e-06	4.91e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—HRAS—hematologic cancer	5.21e-06	4.7e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—IL6—hematologic cancer	4.99e-06	4.5e-05	CbGpPWpGaD
Mimosine—CCL2—Signaling Pathways—AKT1—hematologic cancer	4.6e-06	4.15e-05	CbGpPWpGaD
